0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Gastric Cancer Drugs Market Report 2025 - Product Thumbnail Image

Gastric Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Immuno-Oncology Drugs Market Report 2025 - Product Thumbnail Image

Immuno-Oncology Drugs Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Head and Neck Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Oncolytic Virus Therapy Market Report 2025 - Product Thumbnail Image

Oncolytic Virus Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Metastatic Cancer Drugs Market Report 2025 - Product Thumbnail Image

Metastatic Cancer Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Hepatocellular Carcinoma Drugs Market Report 2025 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,490USDGBP
Sarcoma Drugs Market Report 2025 - Product Thumbnail Image

Sarcoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Solid Tumor Cancer Treatment Market Report 2025 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Cancer Immunotherapy Market Report 2025 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$2,999USDGBP
From
EUR$3,750USDGBP
CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 450 Pages
  • Global
From
EUR$5,000USDGBP
Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
EUR$2,500USDGBP
Malignant Pleural Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Advanced Gastric Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
EUR$2,500USDGBP
Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 90 Pages
  • Global
From
EUR$1,500USDGBP
Anti-CD38 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD38 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more